PYC pyc therapeutics limited

alzheimer’s breakthrough

  1. 315 Posts.
    Cambridge Chemists have pinpointed the catalytic trigger for Alzheimer's disease:

    http://www.cam.ac.uk/research/news/scientists-identify-molecular-trigger-for-alzheimers-disease

    Given that a likely therapeutic modality will be in "silencing" the protein(s) triggering the cascade to neuron death - I wonder if this presents Phylogica with an ideal platform:

    - Blood Brain Barrier transversal

    - Cell penetration

    - Protein silencing (mapping to a specific conformal shape)

    Interesting times for the Phylomer technology platform.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.35
Change
-0.010(0.74%)
Mkt cap ! $793.2M
Open High Low Value Volume
$1.39 $1.39 $1.35 $24.94K 18.38K

Buyers (Bids)

No. Vol. Price($)
2 7377 $1.33
 

Sellers (Offers)

Price($) Vol. No.
$1.38 9727 2
View Market Depth
Last trade - 10.06am 21/07/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.